PHK
CODX

Point72 Hong Kong’s Co-Diagnostics CODX Stock Holding History

Point72 Hong Kong’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-73
Closed -$20K – 1857
2020
Q4 		$20K Buy
+73
New +$27K ﹤0.01% 1422
2020
Q3 		– Sell
-10
Closed -$6K – 1235
2020
Q2 		$6K Buy
+10
New +$4.56K ﹤0.01% 1024

Other funds holding CODX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Point72 Hong Kong's CODX Position: Q1 2021 in Review

Point72 Hong Kong sold out of Co-Diagnostics (CODX) in Q1 2021, closing a stake of 73 shares — an estimated $20K sold.

Point72 Hong Kong first reported a position in CODX in Q2 2020 and held it in 2 quarters. The position peaked at $20K in Q4 2020. 95 funds tracked by Wall St. Rank hold CODX as of Q1 2021.

  • Point72 Hong Kong reported no remaining Co-Diagnostics position as of Q1 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 73 Co-Diagnostics shares in Q1 2021, an estimated $20K.
  • Point72 Hong Kong first reported a position in Co-Diagnostics in Q2 2020 and held it in 2 quarters.
  • Point72 Hong Kong's Co-Diagnostics position peaked at $20K in Q4 2020.
  • 95 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2021.

Based on Point72 Hong Kong's 13F filing for Q1 2021, filed 17 May 2021.